Treatment as prevention April 5, 2017 Michael Horberg, MD, devotes his career to transforming how HIV/AIDS patients are treated at Kaiser Permanente and throughout the United States. Read more
Michael Horberg, MD, highlights Hepatitis C screening program December 9, 2016 Michael Horberg, MD, executive director of the Mid-Atlantic Permanente Research Institute, represented Kaiser Permanente at an invitation-only meeting to discuss the evidence for early hepatitis C treatment in the United States. Read more